Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Preclinical safety and efficacy of 24R,25-dihydroxyvitamin D3 or lactosylceramide treatment to enhance fracture repair

Journal of Orthopaedic Translation(2020)10.1016/j.jot.2020.03.013Source: DataRank Database

Preclinical safety and efficacy of 24R,25-dihydroxyvitamin D3 or lactosylceramide treatment to enhance fracture repair is a research paper published in Journal of Orthopaedic Translation (2020). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (13)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Martin Kaufmann ORCID,Alice Arabian,Glenville Jones ORCID,René St‐Arnaud ORCID,Corine Martineau ORCID

Live enrichment

PubMed:32518749 PMC:PMC7270532

NIAMS NIH HHS

Grant: R01 AR070544

National Institutes of Health

Grant: 1R01AR070544-01

Optimal bone fracture repair requires 24,25-dihydroxyvitamin D and its effector molecule, FAM57B2

Réseau de recherche en santé buccodentaire et osseuse

goldLicense: cc-by-nc-nd

publisherhttps://www.sciencedirect.com/science/article/pii/S2214031X20300437/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2214031X20300437?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2214031X20300437?httpAccept=text/plain

repositoryhttps://doaj.org/article/bcd79b3bc1dd4794bd6fd0d4e6483330

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7270532

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

BoneFracturerepairLactosylceramide24,25-Dihydroxyvitamin DFamily With Sequence Similarity 57B, Isoform 2 (Fam57b2)Tram-lag1-cln8 Domain Containing 3B Isoform 2 (Tlcd3b2)RC925-935Original ArticleDiseases of the musculoskeletal system

Preclinical safety and efficacy of 24R,25-dihydroxyvitamin D3 or lactosylceramide treatment to enhance fracture repair

FAIR Checklist

Authors (5)

Funding (3 grants)

Open Access

Topics

Annotations (Europe PMC)